Details for Patent: 9,180,090
✉ Email this page to a colleague
Which drugs does patent 9,180,090 protect, and when does it expire?
Patent 9,180,090 protects QUZYTTIR and is included in one NDA.
This patent has five patent family members in five countries.
Summary for Patent: 9,180,090
| Title: | Non-sedating antihistamine injection formulations and methods of use thereof |
| Abstract: | Disclosed are injectable formulations of cetirizine for treating acute allergic reactions and methods for treating acute allergic reactions. In particular, an intravenous injectable is disclosed as are methods of treating acute allergic reactions. |
| Inventor(s): | Du; Jie (Lansdale, PA) |
| Assignee: | JDP THERAPEUTICS, INC. (Lansdale, PA) |
| Application Number: | 13/644,290 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 9,180,090
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jdp | QUZYTTIR | cetirizine hydrochloride | SOLUTION;INTRAVENOUS | 211415-001 | Oct 4, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | TREATMENT OF ACUTE URTICARIA | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,180,090
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2010266103 | ⤷ Try a Trial | |||
| Canada | 2803987 | ⤷ Try a Trial | |||
| European Patent Office | 2477634 | ⤷ Try a Trial | |||
| Spain | 2616703 | ⤷ Try a Trial | |||
| World Intellectual Property Organization (WIPO) | 2011003074 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
